注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
DBV Technologies SA是一家法國的臨床階段生物製藥公司,致力於通過開發名為Vaskin的技術平台來改變免疫療法的業務。該公司的治療方法基於表皮免疫療法,即EPIT,它是使用Viaskin通過完整皮膚向免疫系統提供生物活性化合物的專有方法。該公司致力於治療患有嚴重食物過敏的患者,包括嬰兒和兒童,對這些患者來說,安全性至關重要,因為將不良過敏原引入血液中會導致嚴重或危及生命的過敏反應,例如過敏性休克。該公司用於過敏治療的產品包括Viaskin花生、Viaskin牛奶和Viaskin雞蛋。該公司在美國運營著一家子公司DBV Technologies Inc。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Pierre-Henri Benhamou | 66 | 2002 | Co-Founder & Member of Scientific Advisory Board |
Gideon Lack | - | - | Member of the Scientific Advisory Board |
Jonathan M. Spergel | - | - | Member of the Scientific Advisory Board |
Michael Rosenblum | - | 2019 | Member of Scientific Advisory Board |
Christophe Dupont | - | - | Member of Advisory Board |
Ravi Madduri Rao | 55 | 2021 | Independent Director |
Emma Guttman-Yassky | - | 2019 | Member of Scientific Advisory Board |
Jim Krueger | - | 2019 | Member of Scientific Advisory Board |
Miriam Merad | - | 2019 | Member of Scientific Advisory Board |
Jean-François Nicolas | - | 2019 | Member of Scientific Advisory Board |
Adora Ndu | 41 | 2021 | Independent Director |
Betty A. Diamond | - | 2021 | Member of Scientific Advisory Board |
Daniele Guyot-Caparros | 64 | 2022 | Independent Director |
Michel de Rosen | 72 | 2018 | Independent Chairman of the Board |
Hugh A. Sampson | 74 | 2015 | Scientific Adviser to the CEO & Chairman of Scientific Advisory Board |
Michael J. Goller | 48 | 2015 | Director |
Daniel Tassé | 63 | 2018 | CEO & Director |
Mailys Ferrere | 61 | 2012 | Director |
Paul-Henri Lambert | 84 | - | Member of the Scientific Advisory Board |
Daniel B. Soland | 67 | 2015 | Independent Director |
Timothy E. Morris | 62 | 2021 | Independent Director |
Julie O'Neill | 57 | 2017 | Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核